USCAP Annual Meeting 2014
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer,
Inc., a global leader focused on the health and safety of people and
the environment, today announced the launch of the Lamina multilabel
slide scanner at the USCAP 2014 Annual Meeting. The Lamina scanner is a
high throughput imaging system designed to help research pathologists to
more easily study protein expression and the relationships between
disease markers in formalin-fixed, paraffin-embedded (FFPE) tissue
sections. This allows research pathologists to gain a deeper
understanding of diseases for the development of more effective
therapies and treatments.
Configured to meet the needs of a larger research facility, the Lamina
scanner includes high-speed brightfield and fluorescence imaging
modalities along with PerkinElmer's proprietary Autofluorescence
Reduction Technology (ART™). It is designed to reduce interference from
autofluorescence -- an unwanted by-product of tissue fixation -- and
fluorophore cross-talk, in which the signal from one fluorophore bleeds
into multiple channels. Both of these effects obscure real signals,
which can result in an incorrect assessment of a slide. The Lamina
scanner delivers these improvements in real-time during whole-slide
scanning, enabling clearer visualization of protein biomarker expression
in fluorescently labeled tissues. As a result, the Lamina scanner allows
users to obtain more accurate information from histological specimens.
"As a leading provider of imaging platforms for disease research,
PerkinElmer routinely engages research pathologists globally so we can
better understand the complexities of studying disease markers and
develop innovative solutions to meet their needs," said Jim Corbett,
President, Diagnostics / Life Sciences & Technology, PerkinElmer. "The
Lamina scanner can help research pathologists more effectively interpret
their images by automating workflows and providing clearer and faster
results. These advanced digital pathology capabilities can help lead to
a better understanding of disease."
The Lamina scanner produces exceptional-quality, digital, whole-slide
images of hematoxylin and eosin, (H&E) immunohistochemistry (IHC) and
immunofluorescence-labeled tissue sections and tissue microarrays
(TMAs), which can be stored and shared electronically without
degradation. The Lamina scanner complements PerkinElmer's comprehensive
portfolio of quantitative
pathology solutions for translational research, which includes the Vectra®
and Nuance®
Multispectral imaging systems, inForm®
Advanced Image Analysis Software, and biomarker reagent platforms.
For more information on the Lamina scanner, please visit our website
or the PerkinElmer booth #216 at USCAP on March 3-5.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
approximately $2.2 billion in 2013, has about 7,600 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Contacts
PerkinElmer, Inc.
Brian Willinsky, +1 781-663-5728
brian.willinsky@perkinelmer.com